Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales Soar : vimarsana.com

GLP-1 injectable drugs like Ozempic and Wegovy made up a significant portion of the company’s annual sales.

Related Keywords

Denmark , France , Finland , French , Danish , Lars Fruergaard Jorgensen , Eli Lilly , Novo Nordisk , Nokia , Glp 1 , Mounjaro , Weight Loss , Wegovy , Ozempic , Diabetes ,